<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-27T20:16:25Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/6346" metadataPrefix="etdms">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/6346</identifier><datestamp>2025-01-10T13:38:02Z</datestamp><setSpec>com_10324_1134</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1213</setSpec></header><metadata><thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.0/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>Treatment of Knee Osteoarthritis with Autologous Mesenchymal Stem Cells: A Pilot Study</title>
<creator>Orozco, Lluis</creator>
<creator>Munar, Anna</creator>
<creator>Soler, Robert</creator>
<creator>Alberca Zaballos, María Mercedes</creator>
<creator>Soler, Francesc</creator>
<creator>Huguet, Marina</creator>
<creator>Sentís, Joan</creator>
<creator>Sánchez García, Ana María de los Ángeles</creator>
<creator>García-Sancho Martín, Francisco Javier</creator>
<subject>Osteoartritis - Tratamiento</subject>
<description>Producción Científica</description>
<description>Osteoarthritis is the most prevalent joint disease and a frequent cause of joint pain, functional loss, and&#xd;
disability. Osteoarthritis often becomes chronic, and conventional treatments have demonstrated only modest clinical&#xd;
benefits without lesion reversal. Cell-based therapies have shown encouraging results in both animal studies and a few&#xd;
human case reports. We designed a pilot study to assess the feasibility and safety of osteoarthritis treatment with&#xd;
mesenchymal stromal cells (MSCs) in humans and to obtain early efficacy information for this treatment.</description>
<date>2014-09-30</date>
<date>2015-09-30</date>
<date>2013</date>
<type>info:eu-repo/semantics/article</type>
<identifier>Transplantation, Junio 2013, vol. 95, n. 12, p. 1535-1541</identifier>
<identifier>0041-1337</identifier>
<identifier>http://uvadoc.uva.es/handle/10324/6346</identifier>
<identifier>10.1097/TP.0b013e318291a2da</identifier>
<identifier>1535</identifier>
<identifier>12</identifier>
<identifier>1541</identifier>
<identifier>Transplantation</identifier>
<identifier>95</identifier>
<language>eng</language>
<rights>info:eu-repo/semantics/openAccess</rights>
<rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</rights>
<rights>Attribution-NonCommercial-NoDerivatives 4.0 International</rights>
<publisher>Lippincott Williams &amp; Wilkins</publisher>
</thesis></metadata></record></GetRecord></OAI-PMH>